Prováděcí nařízení Komise (EU) 2025/2345 ze dne 19. listopadu 2025, kterým se obnovuje schválení dazometu jako účinné látky pro použití v biocidních přípravcích typu 8 v souladu s nařízením Evropského parlamentu a Rady (EU) č. 528/2012

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal productsOJ L 167, 27.6.2012, p. 1 , ELI: http://data.europa.eu/eli/reg/2012/528/oj. , and in particular Article 14(4), point (a), thereof,

The approval of dazomet as an active substance for use in biocidal products of product-type 8 is renewed, subject to the conditions set out in the Annex.

OJ L 167, 27.6.2012, p. 1 , ELI: http://data.europa.eu/eli/reg/2012/528/oj.

(1) Dazomet was included in Annex I to Directive 98/8/EC of the European Parliament and of the CouncilDirective 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (OJ L 123, 24.4.1998, p. 1 , ELI: http://data.europa.eu/eli/dir/1998/8/oj). as an active substance for use in biocidal products of product-type 8 (wood preservatives). Pursuant to Article 86 of Regulation (EU) No 528/2012, it was therefore considered approved under that Regulation subject to the requirements set out in Annex I to Directive 98/8/EC. That inclusion was to expire on 31 July 2022 .

(2) On 26 January 2021 , an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of dazomet for use in biocidal products of product-type 8 (the application). The application was evaluated by the competent authority of Belgium (the evaluating competent authority).

(3) On 14 June 2024 , the evaluating competent authority submitted a recommendation on the renewal of the approval of dazomet to the European Chemicals Agency (the Agency).

(4) In accordance with Article 75(1), second subparagraph, point (a), of Regulation (EU) No 528/2012, the Biocidal Products Committee prepares the opinion of the Agency regarding the applications for renewal of approval of active substances. The Biocidal Products Committee adopted the opinion of the Agency on 25 February 2025 Biocidal Products Committee (BPC), Opinion on the application for renewal of the approval of the active substance: Dazomet, Product type: 8, ECHA/BPC/458/2025, adopted on 25 February 2025 . , having regard to the conclusions of the evaluating competent authority.

(5) In its opinion, the Agency concluded that biocidal products of product-type 8 containing dazomet may be expected to still satisfy the criteria laid down in Article 19(1), point (b), of Regulation (EU) No 528/2012, provided that certain conditions concerning their use are complied with. Therefore, the conditions for renewal set out in Article 12(1), read in conjunction with Article 4(1), of Regulation (EU) No 528/2012 are considered satisfied.

(6) It is therefore appropriate to renew the approval of dazomet for use in biocidal products of product-type 8, subject to compliance with certain conditions, including a condition for placing on the market of treated articles treated with or incorporating dazomet in line with Article 58(2) and (3) of Regulation (EU) No 528/2012.

(7) A period of transition should be set for new requirements concerning the placing on the market of treated articles treated with or incorporating dazomet in order to allow sufficient time for economic operators to adapt.

(8) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (OJ L 123, 24.4.1998, p. 1 , ELI: http://data.europa.eu/eli/dir/1998/8/oj).

Article 1 Article 1

Article 2 Article 2

Biocidal Products Committee (BPC), Opinion on the application for renewal of the approval of the active substance: Dazomet, Product type: 8, ECHA/BPC/458/2025, adopted on 25 February 2025 .

HAS ADOPTED THIS REGULATION: